Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|April 4, 2012
Discovery of a novel alpha-7 nicotinic acetylcholine receptor agonist series and characterization of the potent, selective, and orally efficacious agonist 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (SEN15924, WAY-361789)Riccardo Zanaletti, Laura Bettinetti, Cristiana Castaldo, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin ToxicitySalvatore La Rosa, Tiziana Benicchi, Laura Bettinetti, et al.Psychopharmacology|June 7, 2011
Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625Karen L Marquis, Thomas A Comery, Flora Jow, et al.Proceedings of the National Academy of Sciences of the United States of America|November 9, 2005
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodentNigel H Greig, Tadanobu Utsuki, Donald K Ingram, et al.Journal of Medicinal Chemistry|October 23, 2012
N-[5-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): a medicinal chemistry effort toward an α7 nicotinic acetylcholine receptor agonist preclinical candidateRiccardo Zanaletti, Laura Bettinetti, Cristiana Castaldo, et al.Journal of Neuroinflammation|August 23, 2018
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in ratsCristina Meregalli, Ivan Marjanovic, Carla Scali, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 19, 2016
Multimodal molecular imaging system for pathway-specific reporter gene expressionMarco Rossi, Luisa Massai, Daniela Diamanti, et al.Human Molecular Genetics|January 18, 2014
A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's diseaseMarianne R Smith, Adeela Syed, Tamas Lukacsovich, et al.Nature Chemical Biology|April 8, 2015
siRNA screen identifies QPCT as a druggable target for Huntington's diseaseMaria Jimenez-Sanchez, Wun Lam, Michael Hannus, et al.Journal of Medicinal Chemistry|May 15, 2010
Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)Chiara Ghiron, Simon N Haydar, Suzan Aschmies, et al.Pageof 2